Jenthera Therapeutics Inc.
$75,000.00 CAD
≈ 12 months of average Canadian pay
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2024-2025
- Agreement period
- October 1, 2024 – March 28, 2025
- Reference
- nrc-cnrc:172-2024-2025-Q3-1023213
Published purpose
The project will focus on developing a suite of gene editing complexes capable of delivering gene edits in vivo to specific cell types. The goal is to modify, correct, or enhance cell behaviors, enabling a wide range of new therapeutic developments in key areas. This will expand treatment options and accelerate the company's growth.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported July 30, 2026 from open.canada.ca Grants & Contributions